Publication | Open Access
Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial
140
Citations
32
References
2020
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1